Dana Investment Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.65M | Buy |
226,204
+16,859
| +8% | +$915K | 0.25% | 96 |
|
|
2026
Q1 | $13.1M | Buy |
209,345
+62,808
| +43% | +$5.02M | 0.39% | 54 |
|
|
2025
Q4 | $14M | Buy |
146,537
+16,674
| +13% | +$1.63M | 0.41% | 50 |
|
|
2025
Q3 | $12.7M | Sell |
129,863
-150,709
| -54% | -$15.6M | 0.37% | 58 |
|
|
2025
Q2 | $30.1M | Sell |
280,572
-28,965
| -9% | -$2.93M | 1% | 12 |
|
|
2025
Q1 | $31.2M | Sell |
309,537
-29,111
| -9% | -$2.93M | 1.12% | 12 |
|
|
2024
Q4 | $30.2M | Buy |
338,648
+32,308
| +11% | +$2.84M | 1% | 12 |
|
|
2024
Q3 | $25.7M | Sell |
306,340
-11,963
| -4% | -$943K | 0.85% | 18 |
|
|
2024
Q2 | $24.5M | Sell |
318,303
-6,356
| -2% | -$465K | 0.83% | 20 |
|
|
2024
Q1 | $22.2M | Sell |
324,659
-17,980
| -5% | -$1.16M | 0.74% | 26 |
|
|
2023
Q4 | $19.8M | Sell |
342,639
-23,657
| -6% | -$1.26M | 0.96% | 29 |
|
|
2023
Q3 | $19.3M | Buy |
366,296
+11,390
| +3% | +$597K | 0.99% | 27 |
|
|
2023
Q2 | $19.2M | Sell |
354,906
-7,325
| -2% | -$383K | 0.95% | 32 |
|
|
2023
Q1 | $18.1M | Buy |
362,231
+355,588
| +5,353% | +$16.8M | 0.92% | 36 |
|
|
2022
Q4 | $307K | Hold |
6,643
| – | – | 0.02% | 361 |
|
|
2022
Q3 | $257K | Hold |
6,643
| – | – | 0.01% | 370 |
|
|
2022
Q2 | $248K | Buy |
6,643
+1,205
| +22% | +$49.1K | 0.01% | 387 |
|
|
2022
Q1 | $241K | Buy |
5,438
+650
| +14% | +$28.2K | 0.01% | 325 |
|
|
2021
Q4 | $203K | Sell |
4,788
-6,808
| -59% | -$286K | 0.01% | 323 |
|
|
2021
Q3 | $503K | Hold |
11,596
| – | – | 0.02% | 247 |
|
|
2021
Q2 | $496K | Sell |
11,596
-1,375
| -11% | -$57.8K | 0.02% | 252 |
|
|
2021
Q1 | $501K | Hold |
12,971
| – | – | 0.02% | 249 |
|
|
2020
Q4 | $466K | Sell |
12,971
-12,310
| -49% | -$444K | 0.02% | 245 |
|
|
2020
Q3 | $966K | Hold |
25,281
| – | – | 0.05% | 196 |
|
|
2020
Q2 | $888K | Hold |
25,281
| – | – | 0.05% | 201 |
|
|
2020
Q1 | $825K | Hold |
25,281
| – | – | 0.05% | 188 |
|
|
2019
Q4 | $1.14M | Hold |
25,281
| – | – | 0.05% | 194 |
|
|
2019
Q3 | $1.03M | Sell |
25,281
-1,793
| -7% | -$76K | 0.05% | 192 |
|
|
2019
Q2 | $1.16M | Hold |
27,074
| – | – | 0.06% | 191 |
|
|
2019
Q1 | $1.04M | Hold |
27,074
| – | – | 0.05% | 205 |
|
|
2018
Q4 | $957K | Hold |
27,074
| – | – | 0.05% | 204 |
|
|
2018
Q3 | $1.04M | Buy |
27,074
+4,882
| +22% | +$171K | 0.04% | 214 |
|
|
2018
Q2 | $726K | Buy |
22,192
+11,596
| +109% | +$350K | 0.03% | 217 |
|
|
2018
Q1 | $289K | Buy |
+10,596
| New | +$288K | 0.01% | 246 |
|
Other funds holding BSX
Dana Investment Advisors's BSX Position: Q2 2026 in Review
Dana Investment Advisors increased its Boston Scientific (BSX) stake by 8.1% in Q2 2026, buying an estimated $915K and bringing the position to 226,204 shares worth $9.65M. The position accounts for 0.25% of the portfolio, ranked #96.
Dana Investment Advisors first reported a position in BSX in Q1 2018 and has held it in 34 quarters since. The position peaked at $31.2M in Q1 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Dana Investment Advisors held 226,204 shares of Boston Scientific worth $9.65M as of Q2 2026.
- Dana Investment Advisors bought 16,859 Boston Scientific shares in Q2 2026, an estimated $915K.
- Boston Scientific made up 0.25% of Dana Investment Advisors's portfolio in Q2 2026, its #96 holding.
- Dana Investment Advisors first reported a position in Boston Scientific in Q1 2018 and has held it in 34 quarters since.
- Dana Investment Advisors's Boston Scientific position peaked at $31.2M in Q1 2025.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Dana Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.